Sulodexide Treatment in Patients With Dense Deposit Disease

Summary

The purpose of this study is to see if a medicine called Sulodexide will help prevent or slow down the progression of Membranoproliferative Glomerulonephritis type II/Dense Deposit Disease. Sulodexide is not yet FDA approved and has not been studied in children. Study aim/hypotheses: to measure the efficacy of Sulodexide treatment in patients with the above disease/s.

Timeline

Start

2007-12

Primary completion

2009-12

Completion

2009-12

Drugs

Indications